Vulvar intraepithelial neoplasia (VIN) is a precancerous condition that occurs in the skin of the vulva, the external genitalia of a female. It is caused by the abnormal growth of cells on the vulvar surface. VIN is classified into three grades, where grade 3 is considered the most severe and requires treatment. VIN is most commonly caused by the Human Papillomavirus (HPV), which is transmitted through sexual contact. Other risk factors include smoking, having multiple sexual partners, and having a weakened immune system. Symptoms of VIN include itching, burning, and pain in the vulva, as well as changes in the color and texture of the skin. The condition can also cause bleeding, although this is rare. Diagnosis of VIN is usually done through a combination of techniques, such as colposcopy, biopsy, and HPV testing. Treatment for VIN depends on the grade and may include topical creams, laser therapy, or surgery. It is important to note that VIN is not cancer, but it can lead to the development of cancer if left untreated. Therefore, women should be aware of the risk factors and seek medical help if they experience any of the symptoms.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia